4.7 Review

Research progress on the role of the Wnt signaling pathway in pituitary adenoma

期刊

FRONTIERS IN ENDOCRINOLOGY
卷 14, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2023.1216817

关键词

PA; Wnt signaling pathway; Wnt pathway inhibitors; targeted drugs; non-coding RNA; TME

向作者/读者索取更多资源

This article reviews the pathogenesis of pituitary adenoma and the role of the Wnt signaling pathway. It discusses the potential of combining Wnt pathway inhibitors with immunotherapy for the treatment of pituitary adenoma.
Pituitary adenoma (PA) is the third most common central nervous system tumor originating from the anterior pituitary, but its pathogenesis remains unclear. The Wnt signaling pathway is a conserved pathway involved in cell proliferation, Self-renewal of stem cells, and cell differentiation. It is related to the occurrence of various tumors, including PA. This article reviews the latest developments in Wnt pathway inhibitors and pathway-targeted drugs. It discusses the possibility of combining Wnt pathway inhibitors with immunotherapy to provide a theoretical basis for the combined treatment of PA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据